"Designing Growth Strategies is in our DNA"

Infectious Disease Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Technique (Lateral Flow Immunoassay, Agglutination Test and Others), By Disease (HIV, Hepatitis B Virus, Pneumonia/Streptococcus Associated Infections, RSV, Influenza, Clostridium Difficile Infections, Hepatitis C Virus, Methicillin-Resistant Staphylococcus Aureus, Tuberculosis, and Others), By Disease, COVID-19 Point-of-care (POC) Diagnostics, By End User (Hospital Bedside, Physicians Office Lab, Urgent Care & Retail Clinics and Others), and Regional Forecast, 2023-2030

Last Updated: October 14, 2024 | Format: PDF | Report ID: FBI104307

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Speak to Analyst

man icon
Mail icon
Captcha refresh
  • 2019-2030
  • 2022
  • 2019-2021
  • 180






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X